系统性硬化症中的皮肤基因表达特征:从临床分层到精准医学
Devis Benfaremo1,2, Silvia Agarbati1, Matteo Mozzicafreddo1
1Department of Clinical and Molecular Sciences, Marche Polytechnic University, 60126 Ancona, Italy.
International journal of molecular sciences
|August 26, 2023
概括
系统性硬化症 (SSc) 呈现出不同的患者反应,使临床试验复杂化. 分析皮肤基因表达可以识别个性化治疗的患者亚组,在SSc管理中推进精密医学.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 皮肤病学 皮肤病学
背景情况:
- 系统性硬化症 (SSc) 或硬皮症在临床表现,疾病进展和治疗反应方面表现出显著的异质性.
- 这种异质性为设计有效的临床试验以确定治疗干预措施带来了挑战.
- 最近分子分析和分层技术的进步为个性化治疗策略提供了潜力.
研究的目的:
- 通过计算生物学来审查SSc中皮肤基因表达分析的当前状态.
- 根据皮肤基因签名来分层SSc患者的优点.
主要方法:
- 现有文献的叙述性审查.
- 专注于用于皮肤基因表达分析的计算生物学方法.
- 基于分子形状的患者分层技术的探索.
主要成果:
- 皮肤基因表达分析与计算生物学相结合,可以识别SSc.内的不同患者亚组.
- 基于皮肤基因特征的分层可以揭示受特定治疗干预措施影响的患者子组.
- 这种方法支持SSc.个性化治疗策略的开发.
结论:
- 皮肤基因表达概况和计算分析对于理解SSc异质性至关重要.
- 通过基因签名对患者进行分层,有助于精准医学对SSc管理的方法.
- 这一策略有望改善SSc的治疗疗效和临床试验设计.
更多相关视频
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
5.5K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
484
相关概念视频
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
